Euclid Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-51,253
Closed -$1.48M 557
2016
Q1
$1.48M Sell
51,253
-11,022
-18% -$287K 0.06% 306
2015
Q4
$1.89M Sell
62,275
-86,275
-58% -$2.83M 0.06% 274
2015
Q3
$5.48M Sell
148,550
-28,500
-16% -$1.47M 0.25% 126
2015
Q2
$10.2M Buy
177,050
+139,340
+370% +$7.12M 0.2% 169
2015
Q1
$1.87M Buy
+37,710
New +$1.76M 0.03% 276
2014
Q4
Sell
-52,100
Closed -$3.09M 491
2014
Q3
$3.09M Buy
52,100
+3,550
+7% +$198K 0.02% 446
2014
Q2
$2.28M Sell
48,550
-6,670
-12% -$301K 0.02% 456
2014
Q1
$2.36M Buy
55,220
+13,960
+34% +$616K 0.02% 387
2013
Q4
$1.74M Sell
41,260
-3,150
-7% -$137K 0.01% 498
2013
Q3
$1.83M Buy
44,410
+8,545
+24% +$357K 0.02% 451
2013
Q2
$1.65M Buy
+35,865
New +$1.61M 0.02% 450

Other funds holding THC

Euclid Advisors's THC Position: Q2 2016 in Review

Euclid Advisors sold out of Tenet Healthcare (THC) in Q2 2016, closing a stake of 51,253 shares — an estimated $1.48M sold.

Euclid Advisors first reported a position in THC in Q2 2013 and held it in 11 quarters. The position peaked at $10.2M in Q2 2015. 261 funds tracked by Wall St. Rank hold THC as of Q2 2016.

  • Euclid Advisors reported no remaining Tenet Healthcare position as of Q2 2016 after selling out during the quarter.
  • Euclid Advisors sold 51,253 Tenet Healthcare shares in Q2 2016, an estimated $1.48M.
  • Euclid Advisors first reported a position in Tenet Healthcare in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Tenet Healthcare position peaked at $10.2M in Q2 2015.
  • 261 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2016.

Based on Euclid Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.